Niagen Bioscience (NAGE) Current Leases (2016 - 2025)
Niagen Bioscience (NAGE) has disclosed Current Leases for 13 consecutive years, with $976000.0 as the latest value for Q3 2025.
- On a quarterly basis, Current Leases rose 8033.33% to $976000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $976000.0, a 8033.33% increase, with the full-year FY2024 number at $12000.0, down 98.26% from a year prior.
- Current Leases was $976000.0 for Q3 2025 at Niagen Bioscience, up from $957000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $976000.0 in Q3 2025 to a low of $9000.0 in Q1 2025.
- A 5-year average of $376111.1 and a median of $18500.0 in 2021 define the central range for Current Leases.
- Peak YoY movement for Current Leases: soared 9630.0% in 2024, then tumbled 98.94% in 2025.
- Niagen Bioscience's Current Leases stood at $20000.0 in 2021, then fell by 20.0% to $16000.0 in 2022, then surged by 4218.75% to $691000.0 in 2023, then plummeted by 98.26% to $12000.0 in 2024, then soared by 8033.33% to $976000.0 in 2025.
- Per Business Quant, the three most recent readings for NAGE's Current Leases are $976000.0 (Q3 2025), $957000.0 (Q2 2025), and $9000.0 (Q1 2025).